Found 13 results

Name Type of Offering Accepted Date
Kinex Pharmaceuticals, Inc.
D/A 2015-06-16
Amount To Be Raised Indefinite
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001300699-15-000003
Exclusions or Exemptions 506b
Accepted Date 2015-06-16
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Kinex Pharmaceuticals, Inc.
D 2015-06-16
Amount To Be Raised $10,000,016
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001300699-15-000004
Exclusions or Exemptions 506b
Accepted Date 2015-06-16
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Athenex, Inc.
D 2016-10-07 14:56:55
Amount To Be Raised $50,000,000
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001300699-16-000007
Exclusions or Exemptions 506b
Accepted Date 2016-10-07 14:56:55
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Debt
Kinex Pharmaceuticals LLC
D 2010-01-07
Amount To Be Raised $6,000,000
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001300699-10-000002
Exclusions or Exemptions N/A
Accepted Date 2010-01-07
Type of Offering D
Industry Other Technology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Athenex, Inc.
D 2019-12-11 16:15:23
Amount To Be Raised $60,369,975
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001209191-19-060031
Exclusions or Exemptions 506b
Accepted Date 2019-12-11 16:15:23
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Kinex Pharmaceuticals LLC
D 2012-08-06
Amount To Be Raised $40,000,000
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001300699-12-000001
Exclusions or Exemptions N/A
Accepted Date 2012-08-06
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets $1,000,001 - $5,000,000
Type of Security Equity
Kinex Pharmaceuticals, Inc.
D 2013-12-23
Amount To Be Raised $40,000,000
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001300699-13-000004
Exclusions or Exemptions 506b
Accepted Date 2013-12-23
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets $1,000,001 - $5,000,000
Type of Security Equity
Athenex, Inc.
D 2017-05-02 19:32:34
Amount To Be Raised $20,000,000
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001300699-17-000001
Exclusions or Exemptions 506b
Accepted Date 2017-05-02 19:32:34
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Debt
Kinex Pharmaceuticals LLC
D/A 2010-02-03
Amount To Be Raised $6,000,000
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001300699-10-000003
Exclusions or Exemptions N/A
Accepted Date 2010-02-03
Type of Offering D/A
Industry Other Technology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Kinex Pharmaceuticals LLC
D 2011-04-25
Amount To Be Raised $5,000,000
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001300699-11-000001
Exclusions or Exemptions N/A
Accepted Date 2011-04-25
Type of Offering D
Industry Other Technology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets $1,000,001 - $5,000,000
Type of Security Equity
Kinex Pharmaceuticals, Inc.
D 2015-05-20
Amount To Be Raised $62,799,990
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001300699-15-000001
Exclusions or Exemptions 506b
Accepted Date 2015-05-20
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Athenex, Inc.
D 2018-07-17 16:43:08
Amount To Be Raised $50,000,000
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001209191-18-042869
Exclusions or Exemptions 506b
Accepted Date 2018-07-17 16:43:08
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets Decline to Disclose
Type of Security Equity
Athenex, Inc.
D 2019-05-14 18:43:44
Amount To Be Raised $100,000,000
Associated Brokers / Dealers N/A
CIK Number 0001300699
Filed Document 0001209191-19-029783
Exclusions or Exemptions 506b
Accepted Date 2019-05-14 18:43:44
Type of Offering D
Industry Pharmaceuticals
Offering Tier N/A
Principal Place of Business NEW YORK
Revenue or Assets $25,000,001 - $100,000,000
Type of Security Equity